Prescription drugs among pregnant women in Lome, Togo, West Africa

Potchoo, Y; Redah, D; Gneni, MA; Guissou, IP

HERO ID

4850126

Reference Type

Journal Article

Year

2009

Language

English

PMID

19337728

HERO ID 4850126
In Press No
Year 2009
Title Prescription drugs among pregnant women in Lome, Togo, West Africa
Authors Potchoo, Y; Redah, D; Gneni, MA; Guissou, IP
Journal European Journal of Clinical Pharmacology
Volume 65
Issue 8
Page Numbers 831-838
Abstract Objective: To assess the trends in prescription drugs and the potential repercussions to newborns among pregnant women who attended prenatal consultations and gave birth in the Department of Gynaecology of Tokoin’s University Hospital, Lome (Togo). Methods: A retrospective study of the registers of prenatal visits and deliveries of the eligible population was performed. Results: In total, 184 different drugs were prescribed to 627 pregnant women attending prenatal consultations. The profile of pharmacotherapeutic groups prescribed was: anti-anaemics (33.33%), antimalarial drugs (24.75%), vitamins ± mineral salts, amino acids and appetite stimulants (14.96%) and antispasmodics and anti-emetics (7.22%). The median proportion of prescriptions for each pharmacotherapeutic group increased significantly from the first to third trimester (9.72, 25.17 and 64.00 respectively; P < 0.05). The median number of drugs prescribed did not vary significantly (P = 0.051) with the age groups, parity (P = 0.068) or obstetrical–gynaecological history (P = 0.401); it did, however, increase significantly with the medical–surgical history (P < 0.05). There were complications associated with deliveries that had no obvious cause related to drug prescription, including four cases of minor defects, 28 stillborns, 65 cases of low birth weight and 27 hospitalised newborns for neonatal diseases. Some interventions were needed for safeguarding the health of the mother, the foetus and the newborn. Conclusion: The trends in obtaining prescription drugs and the consumption of drugs by pregnant women can be assessed using multiple parameters. We limited our study to age groups, gestational age, parity and the medical history of the pregnant woman, profile of pharmacotherapeutic groups, median number of drugs prescribed and the potential risks of the drugs used. The results of our retrospective study were not alarming in terms of neonatal outcomes.
Doi 10.1007/s00228-009-0644-5
Pmid 19337728
Wosid WOS:000268309200011
Is Certified Translation No
Dupe Override No
Is Public Yes
Language Text English
Keyword Lome Togo; Pharmacology; Prenatal care; Risk factors
Relationship(s)